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Introduction
Human listeriosis is one of the most serious foodborne bacterial infections. Clinical illness in adults may range from
a mild flu-like illness to bacterial meningitis. Severe disease affects primarily the elderly, pregnant women, newborns,
and adults with impaired immune function. Although Listeria monocytogenes infection in pregnancy may manifest
as a mild flu-like illness in the woman, it can lead to premature delivery, intrauterine death or bloodstream infection
or meningitis in the newborn. The morbidity and mortality of listeriosis is very high, with notified cases invariably
reported as being hospitalised. In England and Wales in 2000, Adak et al (2002) estimated that although listeriosis
accounted for less than 0.1% of all foodborne illness, it accounted for approximately 17% of deaths related to
foodborne illness.1
Surveillance in Ireland 
Prior to 2004, national surveillance for listeriosis was based on a voluntary laboratory survey conducted annually to
fulfil the requirements of the EU Zoonosis Directive. Between 2000 and 2003, 6-7 cases were reported per annum.2
The disease became notifiable on January 1st 2004, and the case definition now used is based on the EU case
definition. It includes ‘clinically compatible cases that have isolation of L. monocytogenes from a normally sterile site’
(http://www.ndsc.ie/hpsc/NotifiableDiseases /CaseDefinitions/). In addition to the basic demographic data usually
collected for notifiable diseases, enhanced information is collected on clinical features and on factors that may have
contributed to illness (e.g. pregnancy, underlying illness, history of consumption of high-risk foods, etc.).
Incidence, 2004-2007
Listeriosis notifications from 2004-
2007 ranged between seven and 21 per
annum (table 1). Cases were distributed
throughout Ireland (table 2) with a
slight seasonal summer peak in
incidence most years (table 1). The
highest incidence was in 2007, when
the crude incidence rate (CIR) was 0.5
per 100,000 (table 1).3
A steady increase in reported cases of
human listeriosis across the EU over
the last eight years is believed to
represent a true change in incidence.4
Overall the reported incidence of
listeriosis across the EU in 2006 was 0.3
per 100,000 (range 0.0-1.0 per
100,000), with Denmark, Finland and
Luxembourg reporting the highest
incidences.5
Risk groups 
It is well established that listeriosis
occurs mainly in elderly individuals,
immunocompromised persons, or other
vulnerable groups such as pregnant
women or neonates.
Of the 37 non-pregnancy-associated adult cases notified between 2004 and 2007 (table 2), 60% were male and the
median age was 72 years (range 30-87 years). Thirty cases (81%) were reported as elderly (>65 years) and/or
suffering from an underlying illness which predisposed them to listeriosis.
In the same time period, there were ten pregnancy-associated cases and four neonatal cases - an average rate of 5.6
notifications per 100,000 live births, 2004-2007a. The increase in listeriosis notifications reported in 2007 was
primarily among pregnancy-related and neonatal cases (table 3). Five of the pregnancy-related cases in 2007 were
non-Irish-born women; three from Eastern Europe, one from Asia and one from Africa. In addition, one of the
neonatal cases was born to an Eastern European mother.3 This increase in the number of pregnancy-associated cases
in Ireland contrasts with recent rises in human listeriosis incidence noted in Germany and in England and Wales
where the increases reported were in the numbers of non-pregnancy-associated adult cases.6 7
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a Rate was calculated using CSO data on births for 2004-2006, and an estimate of 64,000 births for 2007 as data not yet published
Introduction
Hepatitis C infection is a major cause of chronic liver disease and death
worldwide. Transmission of the virus is primarily through sharing
contaminated equipment when injecting drugs or through receipt of
unscreened blood or blood products. Sexual, occupational and perinatal
transmission can also occur but are less common.1 2
Most studies estimate that between 60 and 85% of those infected fail to
clear the virus. According to the World Health Organization, there are
approximately 170 million chronic carriers worldwide.1 2 Chronic infection
can cause slowly progressing liver disease with the most serious effects
usually seen after more than 20 years of infection. It is estimated that 10-
20% of people who are chronically infected will develop cirrhosis or liver
failure, with a median time from infection to cirrhosis of 30 years. The
estimated annual risk of hepatocellular carcinoma (HCC) in patients with
cirrhosis is between one and seven percent.3
Disease progression varies between individuals, with older age at infection,
male sex, higher alcohol consumption and longer duration of infection all
associated with faster progression.1 2 
Hepatitis C can be treated but success rates vary. One of the key factors
affecting response to anti-viral treatment is the genotype of the virus.
Sustained virologic response rates are lower for people with genotype 1
hepatitis C compared to people with genotypes 2 or 3. However, response
rates have improved significantly in recent years with the advent of
combination regimens of pegylated interferons and ribavirin. Sustained
virologic response rates of up to 46% in genotype 1 patients and up to
82% in genotype 2/3 patients have been achieved with these therapies in
clinical trials.4
Methods
Comprehensive data on the epidemiology of hepatitis C in Ireland are
limited. Most of the available information comes from routine surveillance
and from special studies in high prevalence groups such as injecting drug
users (IDUs), prisoners and asylum seekers. The Irish Blood Transfusion
Service (IBTS) also collects data on the prevalence of hepatitis C in blood
donors.
Sources of information about the burden of hepatitis C disease in Ireland
include the hospital inpatient enquiry system (HIPE), the national cancer
registry (NCRI), Central Statistics Office (CSO) mortality data and liver
transplantation data from the National Liver Transplant Centre in St
Vincent’s University Hospital. A national research database has also been
set up to follow the natural history of infection in people infected through
the administration of contaminated blood and blood products prior to the
introduction of screening. The baseline report on this cohort was published
in October 2007 (http://www.ndsc.ie/hpsc/A- Z/HepatitisHIVAIDSand
STIs/HepatitisC/HepatitisCDatabase/
BaselineReport/).5
Results
Hepatitis C notifications 2004-2007
Hepatitis C became a notifiable disease in Ireland in January 2004. Prior to
this it could be notified as viral hepatitis, type unspecified, but most cases
were not reported. Since it became notifiable, rates have been high with
5,357 cases of hepatitis C notified in Ireland between 2004 and 2007
(table 1).
The geographic distribution of cases has been fairly consistent over the 
past four years, with approximately three-quarters of cases notified by the
HSE Eastern area (HSE E) (77%, n = 4,125) (figure 1).
The age and sex distributions of cases have also been quite consistent
between 2004 and 2007. Male cases predominated: 63% of cases were
male (n = 3,387), 35% were female (n = 1,884) and sex was not known for
the remaining 2%. The highest rates were among young to middle-aged
adults, with 92% of cases aged between 20 and 54 years (figure 2). The
median age at notification for females was slightly younger than that for
males at 31 compared to 33 years.
Hepatitis C prevalence data
Injecting drug users and prisoners
Studies of injecting drug users (IDUs) in prisons and IDUs attending
methadone clinics, specialist addiction treatment centres and GPs have
estimated the hepatitis C prevalence in this population to be between 62
and 81%. 6-12
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Table 1. Number of cases and age-standardised notification rates 
(ASR) per 100,000 population for hepatitis C, 2004-2007
Year Number of cases ASR per 100,000
2004 1,130 25.5
2005 1,433 33.4
2006 1,222 28.5
2007 1,572 36.8
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Figure 1. Annual ASR per 100,000 population by HSE area, 2004-
2007
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Figure 2. Mean annual age- and sex-specific notification rates per
100,000 population, 2004-2007
Asylum seekers
Thirty-five to forty percent of all new asylum applicants are screened for
communicable disease in the HSE E. A review of the screening service in
this area was carried out in 2004 and found that over half of those who
availed of screening were tested for hepatitis C antibodies and 1.5% were
positive.13
Blood donor screening
The IBTS blood donor-screening programme detected a hepatitis C
antibody prevalence of 0.02% (43/207,015) in new blood donors
between 1997 and 2006 (personal communication, IBTS, February 2007).
This low prevalence is to be expected as blood donors are unpaid
volunteers, and individuals who are identified as having relevant risk
factors are excluded prior to donation.
Burden of hepatitis C disease
Hepatitis C infection through blood and blood products
Approximately 1,700 people have been infected with hepatitis C through
the administration of blood and blood products in Ireland.5 15 16 These
include recipients of blood transfusions and blood clotting factors,
women infected through anti-D immune globulin and people who
received treatment for renal failure. People infected in this way are “one-
off” cohorts as blood and blood products are now screened for
hepatitis C.
Patients in these cohorts were invited to consent to be included in a
national hepatitis C research database which involved the extraction of
certain data from their medical charts. Participation in the baseline round
of data collection was over 70% and the median time since infection at
baseline was 27 years. Twenty percent of patients with positive
confirmatory tests for hepatitis C antibodies had cleared the virus prior
to testing and the remaining 80% had tested positive for circulating virus
at some stage (PCR positive). Of the patients who tested PCR positive (n
= 746), 9.7% had developed cirrhosis, 1.3% had developed liver
tumours/HCC and 3.5% had died from liver-related disease. Alcohol
consumption in excess of recommended limits was mentioned in the
charts of over half of the patients who died from liver-related disease.
Eighty percent of those who ever tested PCR positive remained PCR
positive at last test.
National Cancer Registry of Ireland
HCC is the most common form of primary liver cancer. The most
important causes worldwide of HCC are chronic infection with hepatitis
B and hepatitis C. Three hundred and seventy-five cases of HCC were
registered with the NCRI between 1994 and 2005 (figure 3) (personal
communication: NCRI, May 2007).
A systematic review of all published data on the prevalence of chronic
hepatitis B and C infection among HCC cases found a prevalence of
hepatitis C antibody positivity of 34.3% from studies in nine European
countries. An additional 6.5% of cases were positive for both hepatitis C
antibodies and hepatitis B surface antigen.17 These prevalences were
27.5% and 2.5% respectively in a smaller study in the United Kingdom.
Therefore, although NCRI data do not specify underlying cause, it is likely
that somewhere in the region of one-third of HCC cases here are anti-
HCV positive.
Central Statistics Office mortality data
The underlying cause of death was reported to be primary liver cancer for
288 people between 1994 and 2005 (figure 3) (personal communication:
CSO, May 2007).
Hospital In-Patient EnquiryData
The HIPE scheme is a computer-based health information system
designed to collect medical and administrative data on discharges and
deaths from acute hospitals (excluding private hospitals). Each discharge
record represents one episode of care and patients may have been
admitted more than once, or to more than one hospital, with the same
diagnosis. HIPE coverage of acute hospitals was 95% between 1999 and
2004. During this period, there were 3,060 discharges with a principal
diagnosis of ‘other specified viral hepatitis without mention of hepatic
coma’. Most of these are likely to have been due to hepatitis C. A further
778 discharges were associated with a principal diagnosis of primary liver
cancer (personal communication: Economic and Social Research Institute,
July 2007).
Liver transplants
The liver unit in St Vincent’s University Hospital, Dublin carried out 311
liver transplants between 2000 and 2006. Twenty-five of these were
known to be a consequence of HCV infection and a further seventeen
were known to be due to hepatitis C plus another indication such as
alcoholic liver disease or hepatocellular carcinoma (personal
communication: Liver Transplant Unit, St Vincent’s University Hospital
Dublin, April 2007).
Discussion
Data on the epidemiology of hepatitis C in Ireland are available from a
variety of sources including routine surveillance and special studies.These
show a high prevalence of hepatitis C in certain populations, namely one-
off cohorts of those infected in the past through administration of blood
and blood products and the ongoing larger cohort of IDUs.The prevalence
in the general population is unknown. Information on hepatitis C in
Ireland is improving. Risk factor information is now being provided on
some patients through the routine notification system. A national
hepatitis C strategy is being developed by the HSE and will be published
in 2008. Further studies and research are needed to address the gaps in
our knowledge. It is hoped that these developments will lead to better
prevention and control of hepatitis C and guide service planning for
those with chronic disease.
Niamh Murphy, Lelia Thornton, HPSC
Acknowledgements
National Cancer Registry of Ireland, Central Statistics Office, the Liver Transplant Unit in St
Vincent’s University Hospital, the Irish Blood Transfusion Service and The Economic and Social
Research Institute (HIPE data).
References available on request
- 3 -EPI-Insight July 2008
0
01
02
03
04
500240023002200210020002999189917991699159914991
sisongaid fo raeY
N
um
be
r o
f c
as
es
0
5
01
51
02
52
03
53
N
um
be
r o
f d
ea
th
s
CCH fo sesac elaM :IRCN CCH fo sesac elameF :IRCN
recnac revil yramirp ot eud shtaed elam :OSC recnac revil yramirp ot eud shtaed elamef :OSC
Figure 3. Number of cases of primary liver cancer registered with the
NCRI by sex, and number of deaths coded to primary liver cancer by
the CSO, 1994-2005
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Human listeriosis: surveillance, epidemiology, transmission and prevention (Cont.)
Morbidity and mortality
In Ireland, between 2004 and 2007, eighteen non-pregnancy-associated
adult cases and three neonates (41%) were reported to have developed
bloodstream infection and/or meningitis. There were two reported
fatalities due to listeriosis (one in a non–pregnant adult and one neonate),
and three intrauterine deaths.
Microbiology
The L. monocytogenes serovars most commonly reported as associated
with human infection are serovars 1/2a, 1/2b and 4b. Isolates can be further
characterised by molecular typing methods to investigate possible links
between cases. In Ireland, there is no official reference laboratory service
for human isolates of Listeria. In previous years, only a handful of human
isolates were typed. Two hospital laboratories have a research interest in
Listeria and during the upsurge in cases in 2007, twelve isolates were
forwarded to the National Salmonella Reference Laboratory (NSRL) for
serotyping and molecular typing by pulsed field gel electrophoresis (PFGE)8
and three to Waterford Regional Hospital (WRH) for ribotyping.
From the results obtained for these fifteen isolates, it appears that the
upsurge in cases was not caused by a single common strain. Two isolates
were indistinguishable both by ribotyping and PFGE providing support for
a possible unrecognised common link. While the predominant serotype from
patients was 4b, 1/2 was the predominant L. monocytogenes serotype from
food (table 4).
Transmission
Transmission of human listeriosis is mainly foodborne (with onward
vertical transmission to the foetus/neonate in the case of pregnancy-
associated cases). The incubation period ranges from three days to ten
weeks, with an average period of three weeks. L. monocytogenes is
ubiquitous in the environment. It has been detected in a variety of raw
foods such as uncooked meats and vegetables as well as in processed foods
contaminated post-processing such as soft cheeses and ready-to-eat
meats, both of which have been implicated internationally in outbreaks.
The foods most often reported as associated with infection are ready-to-
eat refrigerated and processed foods such as pre-prepared cooked and
chilled meals, soft cheeses, cold cuts of meat, pâtés and smoked fish.
Reported consumption of high-risk foods
among cases in Ireland
In Ireland, data on consumption of high-risk foods by listeriosis cases were
collected where available through enhanced surveillance. However, recall
can be poor among those who are very ill or elderly.The period investigated
was four weeks before symptom onset, or in the case of neonatal cases,
four weeks before the end of the pregnancy. In 2007, a number of patients
reported recent consumption of foods considered high-risk for listeriosis, in
particular soft cheese and sliced cooked meats. However, this information
is difficult to interpret in the absence of control group data.
Prevention during pregnancy
As with other food borne illnesses, there are several steps that will help to
reduce the risk of infection with L. monocytogenes during pregnancy:
• Keep foods for as short a time as possible and follow storage instructions
including ‘use by’ and ‘eat by’ dates 
• Cook food thoroughly, especially meat, ensuring that it is cooked through
to the middle 
• Keep uncooked meats separate from vegetables and from cooked and
ready-to-eat foods 
• Wash salads, fruit and raw vegetables thoroughly before eating, or peel if
appropriate 
• Wash hands, knives, and cutting boards after contact with uncooked food 
• Make sure that the refrigerator is working correctly 
• When heating food in a microwave, follow heating and standing times
recommended by the manufacturer 
• Throw away left-over reheated food. Cooked food which is not eaten
immediately should be cooled as rapidly as possible and then stored in
the refrigerator 
• Avoid eating high-risk foods such as raw (unpasteurised) milk or foods
made from raw milk, soft or mould-ripened cheeses (e.g. feta, Brie,
Camembert, blue-veined cheeses), pâté, smoked salmon 
• If contact with ewes at lambing time is unavoidable, wash hands after
handling animals to reduce any possibility of infection.
Summary
Typing (serology and molecular typing) of human L. monocytogenes
isolates during the upsurge in cases in 2007 was invaluable as it supported
the results of public health investigations which suggested an increased
incidence of sporadic disease rather than a large common source outbreak.
The continued support of primary hospital laboratories in forwarding
human Listeria isolates for further studies is appreciated. Typing of isolates
from food or food premises may also be valuable, particularly in the
context of a suspected common source outbreak.
A recent publication by Denny and McLauchlin (2008) highlighted an
opportunity for the establishment of a formalised listeriosis network in
Europe.4 The continued integration of epidemiological and microbiological
information at national level in Ireland will be essential should such a
network be established.
In consequence of the rise in the number of pregnancy-
associated/neonatal cases in 2007, efforts are being made to develop
appropriate messages for pregnant women, in particular those whose first
language is not English. A leaflet highlighting ways to minimise their risk
has been developed for pregnant women by Safefood and will be translated
into several languages. Other useful resources are outlined below:
Useful links 
HPSC factsheets on listeriosis at http://www.ndsc.ie/hpsc/A-
Z/Gastroenteric/Listeriosis/Factsheets/
Safefood leaflet for pregnant women at http://www.safef
oodonline.com/
FSAI report on The control and management of L. monocytogenes
contamination of food chain at http://www.fsai.ie/publication
s/reports/listeria_report.pdf.
P Garvey, P McKeown, HPSC; N deLappe, G Doran, J O’Connor, M
Cormican, NSRL; D Clancy, N Shanaghy, WRH
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